Table 1.
List of the 16 proteins that show decreased secretion by MMP2 KD in CRC cells and increased levels in the plasmas of CRC patients during disease progression from stage I to II.
Accession No | Protein name | Gene name | Plasma (LFQ) | Secretome (SILAC) | ||||
---|---|---|---|---|---|---|---|---|
Z-score | Log2 (MMP2-KD/ control) | p-value | ||||||
CRC I | CRC II | CRC III | CRC IV | |||||
P05556 | Integrin beta-1 | ITGB1 | − 0.77 | 1.46 | − 0.54 | − 0.15 | − 0.97 | 0.005 |
P21926 | CD9 antigen | CD9 | − 0.81 | 1.26 | − 0.82 | 0.37 | − 0.70 | 0.016 |
Q86SQ4 | G-protein coupled receptor 126 | GPR126 | − 0.72 | 1.49 | − 0.36 | − 0.41 | − 1.02 | 0.03 |
P20827 | Ephrin-A1 | EFNA1 | − 1.06 | 1.27 | − 0.47 | 0.27 | − 1.00 | 0.016 |
Q15828 | Cystatin-M | CST6 | − 1.02 | 1.36 | − 0.37 | 0.03 | − 0.97 | 0.045 |
P30530 | Tyrosine-protein kinase receptor UFO | AXL | − 1.38 | 1.02 | 0.3 | 0.07 | − 0.89 | 0.039 |
P22455 | Fibroblast growth factor receptor 4 | FGFR4 | − 0.61 | 1.46 | − 0.7 | − 0.17 | − 0.80 | 0.033 |
P43121 | Cell surface glycoprotein MUC18 | MCAM | − 0.6 | 1.48 | − 0.66 | − 0.23 | − 0.76 | 0.005 |
Q14118 | Dystroglycan | DAG1 | − 0.45 | 1.5 | − 0.4 | − 0.66 | − 0.66 | 0.043 |
P98160 | Basement membrane-specific heparan sulfate proteoglycan core protein | HSPG2 | − 1.03 | 1.3 | 0.22 | − 0.49 | − 0.64 | 0.049 |
P10316 | HLA class I histocompatibility antigen | HLA-A | − 1.21 | 1.16 | − 0.32 | 0.37 | − 0.74 | 0.052 |
P01034 | Cystatin-C | CST3 | − 1.37 | 0.92 | − 0.1 | 0.55 | − 0.72 | 0.06 |
P39060 | Collagen alpha-1(XVIII) chain;Endostatin | COL18A1 | − 0.94 | 1.41 | − 0.4 | − 0.08 | − 0.74 | 0.064 |
O00592 | Podocalyxin | PODXL | − 1.33 | 1.1 | − 0.03 | 0.26 | − 0.62 | 0.09 |
P10909 | Clusterin | CLU | − 1.4 | 0.99 | 0.24 | 0.19 | − 0.85 | 0.092 |
Q99715 | Collagen alpha-1(XII) chain | COL12A1 | − 1.25 | 1.18 | 0.21 | − 0.14 | − 0.60 | 0.122 |